Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Patients:
- Adults aged 18 or older who have been diagnosed with advanced-stage, high-grade ovarian, fallopian tube, or primary peritoneal cancer, and who are currently receiving or have finished platinum-based chemotherapy and may be considered for maintenance therapy after chemotherapy
- People who are able to understand, speak, or read in Spanish
Clinicians (medical providers):
- Gynecologic cancer specialists and advanced practice providers who work at MD Anderson Cancer Center (Houston area locations) or Harris Health System (LBJ Hospital)
Who may not be able to join:
Patients:
- People who are unable or unwilling to sign an informed consent form
Clinicians (medical providers):
- Clinicians who are unable or unwilling to sign an informed consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Larissa Meyer, Meyer, M.D. Anderson Cancer Center
Phone: (713) 745-0973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Decision Regret Scale questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.